Azora Therapeutics, Inc. (AZR) vs SeaStar Medical Holding Corporation (ICU)

Azora Therapeutics, Inc. and SeaStar Medical Holding Corporation are both Biotechnology companies. Azora Therapeutics, Inc. and SeaStar Medical Holding Corporation are of similar size ($10.2M and $9.7M). Azora Therapeutics, Inc. has the higher net margin (0.00% vs −795.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Azora Therapeutics, Inc. leads on 7 and SeaStar Medical Holding Corporation on 4.

Valuation

Metric AZR ICU Biotechnology median
P/E n/m n/m 10.60
P/S n/m 4.55 9.40
P/B n/m 1.82 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 n/m 0.66
EV/Sales n/m 1.99 9.02
Earnings yield (418.81%) (204.71%) (32.88%)
Free cash flow yield (60.34%) (175.54%) (23.13%)

Profitability

Metric AZR ICU Biotechnology median
Gross margin 0.00% 92.64% 68.51%
Operating margin 0.00% (816.75%) 0.00%
Net margin 0.00% (795.50%) 0.00%
Free cash flow margin 0.00% (799.36%) 0.00%
Return on equity 352.60% (356.87%) (51.96%)
Return on assets (322.10%) (160.02%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AZR ICU Biotechnology median
Revenue growth (TTM) — 123.63% 6.76%
EPS growth (last fiscal year) 82.46% 91.16% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AZR ICU Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.63 1.89 4.97
Net debt to EBITDA 0.75 0.99 1.01

Dividend

Metric AZR ICU Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric AZR ICU Biotechnology median
Market cap 9.74m 10.20m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack